I'm Joe Gradyton and I'm Terry Grady. Welcome to this podcast of the People's Pharmacy.

You can find previous podcasts and more information on a range of health topics at people's pharmacy.com.

Timothy Leary gave psychedelic drugs a bad reputation with his advice to turn on, tune in and drop out.

This is the People's Pharmacy with Terry and Joe Grady.

For decades it was virtually impossible for researchers to study the effects of

psychedelic compounds. That was partly because there was no funding and partly due to the classification as controlled substances.

Recent studies have demonstrated promise for compounds like silicibin to ease anxiety resulting from a cancer diagnosis.

Will use of these agents result in therapeutic advances for smoking cessation, post-traumatic stress disorder, or even major depression?

If these compounds prove helpful, is society ready?

Coming up on the People's Pharmacy,

Psychodelics and Mental Health. mental health

headlines.

an experimental drug for Alzheimer disease called Lecanomab

has produced positive results in a clinical trial.

The manufacturer is touting the effectiveness of this anti-amyloid antibody by stating that it can

reduce cognitive decline 27% as measured on a numeric scale.

The trial lasted 18 months and included about 1,800 participants.

They all had mild Alzheimer disease or cognitive impairment.

This is the first anti-amyloid drug to show a statistically significant benefit

against cognitive decline.

Overall, people on the drugs scored 0.45 points better than those on placebo.

The scale is scored from 0 to 18 and includes measurements of problem solving, memory, and personal care.

...